IVUS-XPL: IVUS superior to angiography for guiding DES implantation in long lesions

Original Title: Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. Presenter: Hong S-J.

Patients with long coronary lesions have better clinical results after a year of second generation DES implantation when interventions are guided by IVUS, instead of angiography. The benefit was attributed to a lower revascularization rate of ischemia driven target lesions. For the trial, carried out in 20 Korean centers, researchers included 1,400 patients (mean age 64; 69% male) with chest pain or evidence of myocardial ischemia and diffuse long coronary lesions (visually estimatedstent length of  ≥ 28 mm). All patients received the Xience Prime stent (Abbott Vascular) and dual ATP with aspirin and clopidogrel through6 months or more.

In patients randomized to IVUS guided stent implantation online IVUS measurements were used to select stent size and length; adjunct high-pressure dilation was performed at the discretion of the physicians based on IVUS findings.Physicians could perform IVUS at any step of PCI, but IVUS exam was mandatory after PCI.

The average stent length was 39.3 mm. During procedure, patients in the IVUS arm more frequently received adjunct post-dilation (76% vs 57%) and had a larger mean final balloon size (3.14 vs 3.04 mm; P <0.001 for both). As a result, patients who underwent IVUS-guided procedure had a higher minimum lumen diameter (2.64 vs 2.56 mm; P <0.001) and lower diameter stenosis (12.79% vs 13.74%; P = .04) on post-intervention quantitative coronary angiography.

Patients in the IVUS arm required ischemia driven target lesion revascularization 2.5% of times vs. 5% in the control group.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...